These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2391690

  • 21. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
    Astor M, Hall EJ, Biaglow JE, Parham JC.
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
    [Abstract] [Full Text] [Related]

  • 22. Potential Radiosensitizing Agents III: 2-Nitro-4-acetylimidazole analogs.
    Sehgal RK, Agrawal KC.
    J Pharm Sci; 1982 Nov; 71(11):1203-6. PubMed ID: 7175708
    [Abstract] [Full Text] [Related]

  • 23. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
    Papadopoulou MV, Rosenzweig HS, Bloomer WD.
    Bioorg Med Chem Lett; 2004 Mar 22; 14(6):1523-5. PubMed ID: 15006395
    [Abstract] [Full Text] [Related]

  • 24. Potential radiosensitizing agents. 2. Synthesis and biological activity of derivatives of dinitroimidazole with oxiranes.
    Sehgal RK, Webb MW, Agrawal KC.
    J Med Chem; 1981 May 22; 24(5):601-4. PubMed ID: 7241517
    [Abstract] [Full Text] [Related]

  • 25. The nitroimidazoles as radiosensitizers and cytotoxic agents.
    Hall EJ, Miller R, Astro M, Rini F.
    Br J Cancer Suppl; 1978 Jun 22; 3():120-3. PubMed ID: 277211
    [Abstract] [Full Text] [Related]

  • 26. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities.
    Cowan DS, Matejovic JF, Wardman P, McClelland RA, Rauth AM.
    Int J Radiat Biol; 1994 Dec 22; 66(6):729-38. PubMed ID: 7814971
    [Abstract] [Full Text] [Related]

  • 27. Potential radiosensitizing agents. Dinitroimidazoles.
    Agrawal KC, Bears KB, Sehgal RK, Brown JN, Rist PE, Rupp WD.
    J Med Chem; 1979 May 22; 22(5):583-6. PubMed ID: 379334
    [Abstract] [Full Text] [Related]

  • 28. Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency.
    Adams GE, Clarke ED, Flockhart IR, Jacobs RS, Sehmi DS, Stratford IJ, Wardman P, Watts ME, Parrick J, Wallace RG, Smithen CE.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1979 Feb 22; 35(2):133-50. PubMed ID: 312783
    [Abstract] [Full Text] [Related]

  • 29. Hypoxic cell radiosensitizers--chemical aspects and in vitro models.
    Wardman P.
    Strahlentherapie Sonderb; 1978 Feb 22; 75():20-6. PubMed ID: 555049
    [No Abstract] [Full Text] [Related]

  • 30. Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro.
    Naylor MA, Threadgill MD, Showalter HD, Stratford IJ, Stephens MA, Fielden EM, Adams GE.
    Drug Des Discov; 1993 Feb 22; 10(3):249-55. PubMed ID: 8268395
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and activity of novel nitropyrazines for use as hypoxic cell radiosensitizers.
    Hartman GD, Hartman RD, Schwering JE, Saari WS, Engelhardt EL, Jones NR, Wardman P, Watts ME, Woodcock M.
    J Med Chem; 1984 Dec 22; 27(12):1634-9. PubMed ID: 6389865
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Assessment of a range of novel nitro-aromatic radiosensitizers and bioreductive drugs.
    Fielden EM, Adams GE, Cole S, Naylor MA, O'Neill P, Stephens MA, Stratford IJ.
    Int J Radiat Oncol Biol Phys; 1992 Dec 22; 22(4):707-11. PubMed ID: 1544842
    [Abstract] [Full Text] [Related]

  • 34. Testing of hypoxic cell radiosensitizers in vivo.
    Rauth AM, Chin J, Marchow L, Paciga J.
    Br J Cancer Suppl; 1978 Jun 22; 3():202-5. PubMed ID: 277228
    [Abstract] [Full Text] [Related]

  • 35. Radiosensitizing hypoxic cells with new 3-nitro-1,2,4-triazole derivatives in vitro and in vivo.
    Nagao Y, Sano S, Ochiai M, Fuji K, Nishimoto S, Kagiya T, Murayama C, Mori T, Shibamoto Y, Sasai K.
    Chem Pharm Bull (Tokyo); 1989 Jul 22; 37(7):1951-3. PubMed ID: 2805177
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies.
    Cowan DS, Matejovic JF, McClelland RA, Rauth AM.
    Br J Cancer; 1994 Dec 22; 70(6):1067-74. PubMed ID: 7981056
    [Abstract] [Full Text] [Related]

  • 38. 4-Fluorobenzylamine and phenylalanine methyl ester conjugates of 2-nitroimidazole: evaluation as hypoxic cell radiosensitizers.
    Garg PK, Garg S, Degraff WG, Zalutsky MR, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1992 Dec 22; 22(3):593-6. PubMed ID: 1531220
    [Abstract] [Full Text] [Related]

  • 39. Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.
    Stratford IJ, Williamson C, Hardy C.
    Br J Cancer; 1981 Jul 22; 44(1):109-16. PubMed ID: 7259957
    [Abstract] [Full Text] [Related]

  • 40. In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique.
    Rauth AM, Kaufman K.
    Br J Radiol; 1975 Mar 22; 48(567):209-20. PubMed ID: 1125550
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.